Geographical origin of chronic Chagas disease patients in Brazil impacts the performance of commercial tests for anti-T. cruzi IgG

BACKGROUND: Chagas disease, caused by Trypanosoma cruzi, affects nearly six million people worldwide. Various serological tests have been developed for its diagnosis. OBJECTIVE: Examine the performance of a set of commercial immunological assays in relation to the geographical origin of the patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Sáez-Alquezar, Amadeo, Junqueira, Angela Cristina Verissimo, Durans, Andressa da Matta, Guimarães, André Valpassos, Corrêa, José Abol, Borges-Pereira, José, Zauza, Patrícia Lago, Cabello, Pedro Hernan, Albajar-Viñas, Pedro, Provance, David William, Coura, José Rodrigues
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168343/
http://dx.doi.org/10.1590/0074-02760210032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168343/
http://dx.doi.org/10.1590/0074-02760210032

Ejemplares similares